News Category
VERAXA Biotech is implementing FDA-aligned New Approach Methodologies to cut animal testing in preclinical research, potentially accelerating cancer t...
Lantern Pharma's regulatory and IRB approvals in Taiwan for Part 2 of its Phase 2 HARMONIC trial of LP-300 mark a significant step forward in addressi...
VERAXA Biotech (NASDAQ: VRXA) is implementing FDA-aligned New Approach Methodologies to reduce animal testing and accelerate the development of its an...
New research reveals that the skull harbors lymph node-like structures that could mobilize an immune response against brain diseases, potentially tran...
GeoVax's preclinical data demonstrate that a single dose of its next-generation MVA-X vaccine provides durable protection against highly pathogenic Cl...
Onco-Innovations is aligning its manufacturing, preclinical, and clinical planning efforts to move its lead cancer candidate ONC010 toward potential f...
New guidance from experts emphasizes that small cell lung cancer patients should ask about clinical trials at their first appointment, as emerging the...
Telomir Pharmaceuticals reports that Telomir-Zn inhibited growth in human and canine osteosarcoma cell lines at similar low concentrations, supporting...
Dr. Wael Sakr has announced a one-time $1,000 scholarship for undergraduate pre-med students across the United States, aiming to ease financial burden...
Creative Biolabs has enhanced its single-cell multi-omics and RNA sequencing services to help researchers overcome sample processing challenges and un...
A new review reveals that the tumor microenvironment actively shapes natural killer cells into distinct subsets with specialized roles, offering a new...
The September 17 Life Sciences Virtual Investor Forum will feature seven companies presenting advancements in cancer therapy, antibiotics, drug delive...
VERAXA Biotech's appointment of Dr. Christoph Erkel as chief scientific officer signals a strategic push to advance its BiTAC® technology and oncology...
Quantum BioPharma's Lucid-MS, a novel non-immune-suppressing multiple sclerosis therapy, advances toward Phase 2 trials after FDA IND clearance, poten...
Onco-Innovations' CMO discussed the company's lead drug candidate ONC010, which targets the DNA repair enzyme PNKP and uses two selectivity mechanisms...
Quantum BioPharma's Lucid-MS, a first-in-class PAD2 inhibitor, has received FDA clearance to begin a Phase 2 trial in multiple sclerosis, potentially ...
Kairos Pharma's CEO will present at a major investment conference, underscoring the company's progress in developing ENV-105 to reverse cancer drug re...
GeoVax supports the new global mpox vaccine stockpile and emphasizes its GEO-MVA candidate's potential to enhance supply diversity and preparedness.
VERAXA Biotech's appointment of Raju Willener as CFO signals a strategic move to strengthen its financial leadership and advance its oncology pipeline...
Onco-Innovations advances its oncology pipeline by building manufacturing readiness, IND-enabling activities, and financial support, reducing executio...
OS Animal Health's presentation at the Moody Capital Solutions Disruptive Growth & Life Sciences Conference highlights its progress in securing USDA c...
Quantum BioPharma's FDA clearance for Lucid-MS phase 2 trial introduces a first-in-class myelin repair approach that could transform MS treatment by p...
Researchers at Washington University School of Medicine have advanced laser interstitial thermal therapy (LITT) as a less invasive alternative to open...
Quantum BioPharma's FDA clearance for a Phase 2 trial of Lucid-MS marks a historic step toward a first-in-class therapy targeting myelin repair, poten...
NanoViricides has registered its Phase II Ebola trial for NV-387 Oral Gummies in the Pan African Clinical Trials Registry, marking a critical step in ...
Quantum BioPharma's FDA clearance to initiate a Phase 2 trial of Lucid-MS marks a pivotal step toward a targeted therapy for multiple sclerosis, poten...
Recent FDA authorization of ZYN nicotine pouches with modified risk claims highlights a pivotal shift in tobacco policy, aiming to balance historicall...
A large cohort study reveals that the timing of brain metastasis development significantly impacts survival in colorectal cancer patients, highlightin...
Onco-Innovations has moved its lead PNKP inhibitor ONC010 closer to human trials by achieving high-purity API production and establishing a regulatory...
VERAXA Biotech's appointment of Raju Willener as CFO underscores its commitment to advancing its BiTAC platform and oncology pipeline through seasoned...
OS Therapies' participation in the Moody Capital conference underscores its strategic positioning ahead of critical regulatory decisions for its lead ...
A Swiss-led preclinical study reveals that administering immunotherapy before surgery significantly improves glioblastoma treatment outcomes, offering...
A Mass General Brigham study finds that unintended radiation to the thymus during lung cancer treatment is associated with poorer clinical outcomes, h...
Salman Fazal, MD, a hematologist and stem cell transplant expert at UPMC Hillman Cancer Center in Harrisburg, has been named a 2026 Castle Connolly To...
NanoViricides is moving its measles drug candidate NV-387 into Phase II trials, leveraging FDA designations that could expedite development and offer ...
TransCode Therapeutics' lead candidate TTX-MC138 showed significant survival benefits and reduced miR-10b expression in a preclinical breast cancer bo...
Prostate cancer experts and a patient advocate emphasize the importance of PSMA PET imaging in guiding treatment decisions, urging men to discuss this...
A nurse's personal battle with metastatic triple-negative breast cancer underscores the significance of newer treatments like antibody-drug conjugates...
The NMPA approval allows Heidelberg Pharma and Huadong Medicine to advance HDP-101 combination therapy for multiple myeloma, expanding its potential a...
A peer-reviewed study in Critical Care Medicine validates VolitionRx's Nu.Q NETs H3.1 biomarker as an independent predictor of mortality and renal rep...
Novogenia AG introduces its expanded MGT Plus methylation test in the U.S., covering 27 genes across six pathways, to enhance personalized prevention ...
Citius Pharmaceuticals' commercial launch of LYMPHIR and its late-stage pipeline, including Mino-Lok and Halo-Lido, position the company to address si...
Annovis Bio's upcoming webinar highlights its pivotal Phase 3 Alzheimer's trial and expansion into Parkinson's disease, signaling progress in neurodeg...
A new study suggests that a personalized mRNA vaccine derived from a patient's tumor tissue may prevent melanoma recurrence for years, highlighting th...
Creative Biolabs announces an expert webinar on modeling T cell dysfunction in the tumor microenvironment, highlighting the importance of advanced pre...
Dr. David Zelby's recognition as a Castle Connolly Top Dentist underscores his decades of expertise in prosthodontics and his commitment to comprehens...
A novel T cell therapy may provide a new treatment avenue for recurrent glioblastoma, a condition with limited options, highlighting the importance of...
VERAXA Biotech and Secarna Pharmaceuticals announced initial positive results from their collaboration to develop AOCs for autoimmune diseases, showin...
